• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Axcelis Announces Financial Results for Third Quarter 2025

    11/4/25 7:00:00 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology
    Get the next $ACLS alert in real time by email

    Q3 Highlights:

    • Revenue of $213.6 million
    • GAAP Gross Margin of 41.6%, and Non-GAAP Gross Margin of 41.8%
    • GAAP Operating Margin of 11.7% and Non-GAAP Operating Margin of 18.2%
    • GAAP Diluted earnings per share of $0.83, and Non-GAAP Diluted earnings per share of $1.21

    BEVERLY, Mass., Nov. 4, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the third quarter ended September 30, 2025.

    Axcelis (PRNewsfoto/Axcelis Technologies, Inc.)

    President and CEO Russell Low commented, "We delivered another solid quarter, with sales and earnings both exceeding our expectations. We are also pleased to report record CS&I revenue in the quarter, reflecting the success of our aftermarket strategy and the continued expansion of our installed base. We are executing on our product development roadmap and customer engagement initiatives with focus and urgency, while maintaining disciplined cost controls. These actions have enabled us to successfully navigate the anticipated cyclical digestion period across our markets in 2025."

    Low added, "We entered the fourth quarter with a solid financial foundation and are well poised to execute on our strategy as we enter into our next chapter of growth and innovation. Our recently announced merger with Veeco Instruments marks a critical milestone that we believe will position the combined company to capitalize on powerful secular tailwinds including AI and electrification. By bringing our two companies together, we believe we are building a leading semiconductor equipment company with the capabilities, resources and financial foundation to drive sustainable growth and value creation for shareholders and deliver meaningful benefits to all stakeholders."

    Executive Vice President and Chief Financial Officer Jamie Coogan stated, "We generated robust operating leverage through higher volume and disciplined cost management, translating into strong free cash flow. With over $590 million in cash and investments on the balance sheet, Axcelis has ample flexibility to capitalize on our value-enhancing strategic initiatives and long-term growth priorities."

    Results Summary 

    (In thousands, except per share amounts and percentages)







    Three months ended September 30,





    2025





    2024



    Revenue

    $

    213,611



    $

    256,564



    Gross margin



    41.6 %





    42.9 %



    Operating margin



    11.7 %





    18.3 %



    Net income

    $

    25,986



    $

    48,576



    Diluted earnings per share

    $

    0.83



    $

    1.49



     Non-GAAP Results



    Non-GAAP gross margin



    41.8 %





    43.0 %

    Non-GAAP operating margin



    18.2 %





    21.7 %

    Adjusted EBITDA

    $

    43,202



    $

    59,674

    Non-GAAP net income

    $

    37,900



    $

    56,191

    Non-GAAP diluted earnings per share

    $

    1.21



    $

    1.72

     

    Business Outlook

    For the fourth quarter ending December 31, 2025, Axcelis expects revenues of approximately $215 million, GAAP earnings per diluted share of approximately $0.76, and non-GAAP earnings per share of approximately $1.12.

    Please refer to Fourth Quarter Outlook under the "Notes on our Non-GAAP Financial Information" section of this document for detail relating to the computation of non-GAAP earnings per diluted share as well as the Safe Harbor Statement section of this document.

    Third Quarter 2025 Conference Call

    The Company will host a call today to discuss the results at 8:30 a.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a participant here:

    https://register-conf.media-server.com/register/BI7b3b54c06ff14c8080f379ce76dc7cab

    Webcast replays will be available for 30 days following the call.

    Use of Non-GAAP Financial Results

    This press release includes financial measures that are not presented in accordance with U.S. generally accepted accounting principles ("non-GAAP financial measures"). These non-GAAP financial measures include non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP income tax provision, Adjusted EBITDA, non-GAAP net income, and non-GAAP diluted earnings per share, and reflect adjustments for the impact of share-based compensation expense, certain items related to restructuring and severance charges and any associated adjustments and transaction and integration costs associated with the merger agreement with Veeco Instruments announced on October 1, 2025.

    Reconciliations of these non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with GAAP are provided in the financial tables included in this release.

    For further information regarding these non-GAAP financial measures, please refer to the tables presenting reconciliations of our non-GAAP results to our GAAP results and the "Notes on Our Non-GAAP Financial Information" at the end of this press release.

    Safe Harbor Statement

    This press release contains, and the conference call will contain, forward-looking statements under the Private Securities Litigation Reform Act safe harbor provisions. These statements, which include our expectations for spending in our industry and guidance for future financial performance, are based on management's current expectations and should be viewed with caution. They are subject to various risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are outside the control of the Company, including that customer decisions to place orders or our product shipments may not occur when we expect, that orders may not be converted to revenue in any particular quarter, or at all, whether demand will continue for the semiconductor equipment we produce or, if not, whether we can successfully meet changing market requirements, and whether we will be able to maintain continuity of business relationships with and purchases by major customers and, with respect to the potential transaction with Veeco, failure to obtain applicable regulatory or stockholder approvals in a timely manner or otherwise; failure to satisfy other closing conditions to the proposed transaction or to complete the proposed transaction on anticipated terms and timing; negative effects of the announcement of the proposed transaction; risks that the businesses will not be integrated successfully or that the combined company will not realize expected benefits, cost savings, accretion, synergies and/or growth, or that such benefits may take longer to realize or may be more costly to achieve than expected; the risk that disruptions from the proposed transaction will harm business plans and operations; risks relating to unanticipated costs of integration; significant transaction and/or integration costs, or difficulties in connection with the proposed transaction and/or unknown or inestimable liabilities; restrictions during the pendency of the proposed transaction that may impact the ability to pursue certain business opportunities or strategic transactions; potential litigation associated with the proposed transaction; the potential impact of the announcement or consummation of the proposed transaction on the Company's, Veeco's or the combined company's relationships with suppliers, customers, employees and regulators; and demand for the combined company's products. Actual results may differ materially from those projected in such statements due to various factors, including but not limited to: economic, political and social conditions in the countries in which the Company and Veeco, their respective customers and suppliers operate; disruption to the Company's and Veeco's respective manufacturing facilities or other operations, or the operations of Company's and Veeco's respective customers and suppliers, due to natural catastrophic events, health epidemics or terrorism; ongoing changes in the technology industry, and the semiconductor industry in particular, including future growth rates, pricing trends in end-markets, or changes in customer capital spending patterns; the Company's, Veeco's and the combined company's ability to timely develop new technologies and products that successfully anticipate or address changes in the semiconductor industry; the Company's, Veeco's and the combined company's ability to maintain their respective technology advantage and protect their respective proprietary rights; the Company's, Veeco's and the combined company's ability to compete with new products introduced by their respective competitors; the Company's, Veeco's and the combined company's ability or the ability of their respective customers to obtain U.S. export control licenses for the sale of certain products or provision of certain services to customers in China. Increased competitive pressure on sales and pricing, increases in material and other production costs that cannot be recouped in product pricing and instability caused by changing global economic, political or financial conditions, including with respect to the imposition of tariffs on our products or components of our products, could also cause actual results to differ materially from those in our forward-looking statements. These risks and other risk factors relating to Axcelis are described more fully in the most recent Form 10-K filed by Axcelis and in other documents filed from time to time with the Securities and Exchange Commission.

    About Axcelis:

    Axcelis (NASDAQ:ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for over 45 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.

    CONTACTS:

    Investor Relations Contact:

    David Ryzhik

    Senior Vice President, Investor Relations and Corporate Strategy

    Telephone: (978) 787-2352

    Email: [email protected]

    Press/Media Relations Contact:

    Maureen Hart

    Senior Director, Corporate & Marketing Communications

    Telephone: (978) 787-4266

    Email: [email protected]

    Axcelis Technologies, Inc.

    Consolidated Statements of Operations

    (In thousands, except per share amounts)

    (Unaudited)











    Three months ended



    Nine months ended









    September 30,



    September 30,







    2025



    2024



    2025



    2024



    Revenue:



























    Product



    $

    201,218



    $

    246,826



    $

    567,444



    $

    735,626



    Services





    12,393





    9,738





    33,274





    29,822



    Total revenue





    213,611





    256,564





    600,718





    765,448



    Cost of revenue:



























    Product





    112,078





    136,379





    302,041





    399,049



    Services





    12,727





    10,215





    33,761





    27,968



    Total cost of revenue





    124,805





    146,594





    335,802





    427,017



    Gross profit





    88,806





    109,970





    264,916





    338,431



    Operating expenses:



























    Research and development





    24,640





    26,395





    78,832





    77,843



    Sales and marketing





    15,838





    16,808





    45,965





    51,483



    General and administrative





    23,308





    19,854





    56,976





    52,842



    Total operating expenses





    63,786





    63,057





    181,773





    182,168



    Income from operations





    25,020





    46,913





    83,143





    156,263



    Other income (expense):



























    Interest income





    5,465





    6,560





    16,547





    18,126



    Interest expense





    (1,305)





    (1,333)





    (4,028)





    (4,017)



    Other, net





    970





    3,225





    2,569





    1,257



    Total other income





    5,130





    8,452





    15,088





    15,366



    Income before income taxes





    30,150





    55,365





    98,231





    171,629



    Income tax provision





    4,164





    6,789





    12,290





    20,593



    Net income



    $

    25,986



    $

    48,576



    $

    85,941



    $

    151,036



    Net income per share:



























    Basic



    $

    0.83



    $

    1.49



    $

    2.70



    $

    4.63



    Diluted



    $

    0.83



    $

    1.49



    $

    2.70



    $

    4.61



    Shares used in computing net income per share:



























    Basic weighted average shares of common stock





    31,287





    32,550





    31,796





    32,595



    Diluted weighted average shares of common stock





    31,450





    32,675





    31,863





    32,780



     

    Axcelis Technologies, Inc.

    Consolidated Balance Sheets

    (In thousands, except per share amounts)

    (Unaudited)











    September 30,



    December 31,







    2025



    2024



    ASSETS



    Current assets:















    Cash and cash equivalents



    $

    187,501



    $

    123,512



    Short-term investments





    262,059





    447,831



    Accounts receivable, net





    147,636





    203,149



    Inventories, net





    324,342





    282,225



    Prepaid income taxes





    4,687





    6,420



    Prepaid expenses and other current assets





    57,804





    60,471



    Total current assets





    984,029





    1,123,608



    Property, plant and equipment, net





    57,979





    53,784



    Operating lease assets





    29,499





    29,621



    Finance lease assets, net





    14,440





    15,346



    Long-term restricted cash





    7,626





    7,552



    Deferred income taxes





    70,033





    68,277



    Long-term investments





    143,214





    -



    Other assets





    45,120





    50,593



    Total assets



    $

    1,351,940



    $

    1,348,781



    LIABILITIES AND STOCKHOLDERS' EQUITY



    Current liabilities:















    Accounts payable



    $

    52,466



    $

    46,928



    Accrued compensation





    24,357





    25,536



    Warranty





    9,258





    13,022



    Deferred revenue





    81,486





    94,673



    Current portion of finance lease obligation





    1,505





    1,345



    Other current liabilities





    29,917





    26,018



    Total current liabilities





    198,989





    207,522



    Long-term finance lease obligation





    41,166





    42,329



    Long-term deferred revenue





    47,434





    43,501



    Other long-term liabilities





    44,207





    42,639



    Total liabilities





    331,796





    335,991



















    Stockholders' equity:















    Common stock, $0.001 par value, 75,000 shares authorized; 30,998 shares issued and

    outstanding at September 30, 2025; 32,365 shares issued and outstanding at December 31,

    2024





    31





    32



    Additional paid-in capital





    532,951





    548,654



    Retained earnings





    488,771





    470,318



    Accumulated other comprehensive loss





    (1,609)





    (6,214)



    Total stockholders' equity





    1,020,144





    1,012,790



    Total liabilities and stockholders' equity



    $

    1,351,940



    $

    1,348,781



















     

    Axcelis Technologies, Inc.

    Condensed Consolidated Statements of Cash Flows

    (In thousands)

    (Unaudited)





    Three months ended





    Nine months ended







    September 30,





    September 30,







    2025



    2024





    2025





    2024





    Cash flows from operating activities

























    Net income

    $

    25,986



    $

    48,576



    $

    85,941



    $

    151,036



    Adjustments to reconcile net income to net cash provided by operating

    activities:

























    Depreciation and amortization



    4,328





    3,906





    13,152





    11,542



    Stock-based compensation expense



    5,344





    5,412





    15,668





    15,571



    Other



    6,907





    (16,346)





    (4,110)





    (11,090)



    Change in other assets and liabilities, net



    2,785





    4,200





    14,221





    (39,021)



    Net cash provided by operating activities



    45,350





    45,748





    124,872





    128,038





























    Cash flows from investing activities

























    Expenditures for property, plant and equipment and capitalized software



    (2,015)





    (3,899)





    (8,960)





    (7,523)



    Other changes in investing activities, net



    3,393





    (52,654)





    46,194





    (110,324)



    Net cash provided by (used in) investing activities



    1,378





    (56,553)





    37,234





    (117,847)





























    Cash flows from financing activities

























    Repurchase of common stock



    (32,335)





    (15,363)





    (95,850)





    (45,358)



    Other changes from financing activities, net



    (440)





    (630)





    (4,022)





    (11,291)



    Net cash used in financing activities



    (32,775)





    (15,993)





    (99,872)





    (56,649)





























    Effect of exchange rate changes on cash and cash equivalents



    (106)





    1,700





    1,829





    (774)



    Net increase (decrease) in cash, cash equivalents and restricted cash



    13,847





    (25,098)





    64,063





    (47,232)





























    Cash, cash equivalents and restricted cash at beginning of period



    181,280





    151,817





    131,064





    173,951



    Cash, cash equivalents and restricted cash at end of period

    $

    195,127



    $

    126,719



    $

    195,127



    $

    126,719











































     

    Notes on Our Non-GAAP Financial Information

    Management uses non-GAAP gross profit, gross margin, operating income, operating margin, income tax provision, net income, diluted earnings per share, and Adjusted EBITDA to evaluate the Company's operating and financial performance and for planning purposes. Axcelis believes these measures enhance an overall understanding of its performance and investors' ability to review the Company's business from the same perspective as the Company's management. 

    There are limitations in using non-GAAP financial measures because the non-GAAP financial measures are not prepared in accordance with GAAP, may be different from non-GAAP financial measures used by other companies, and may exclude certain items that may have a material impact upon our reported financial results. The presentation of this additional information is not meant to be considered in isolation or as a substitute for the directly comparable financial measures prepared in accordance with GAAP.

    Totals presented may not sum and percentages may not recalculate using figures presented due to rounding.

    Axcelis Technologies, Inc.

    Schedule Reconciling Selected Non-GAAP Financial Measures

    (In thousands, except per share amounts)









    Three months ended September 30,







    Nine months ended September 30,







    2025





    2024





    2025





    2024

    GAAP gross Profit

    $

    88,806



    $

    109,970



    $

    264,916



    $

    338,431

    Restructuring1



    -





    -





    226





    876

    Stock-based compensation



    499





    354





    1,421





    1,106

    Non-GAAP gross profit

    $

    89,305



    $

    110,324



    $

    266,563



    $

    340,413

    Non-GAAP gross margin



    41.8 %





    43.0 %





    44.4 %





    44.5 %

























    GAAP operating expense

    $

    63,786



    $

    63,057



    $

    181,773



    $

    182,168

    Transaction and integration3



    (8,274)





    -





    (8,274)





    -

    Bad debt expense



    -





    (3,443)





    -





    (2,984)

    Restructuring1



    (236)





    -





    (1,130)





    (553)

    Stock-based compensation



    (4,845)





    (5,058)





    (14,247)





    (14,465)

    Non-GAAP operating expense

    $

    50,431



    $

    54,556



    $

    158,122



    $

    164,166

























    GAAP operating income

    $

    25,020



    $

    46,913



    $

    83,143



    $

    156,263

    Transaction and integration3



    8,274





    -





    8,274





    -

    Bad debt expense



    -





    3,443





    -





    2,984

    Restructuring1



    236





    -





    1,356





    1,429

    Stock-based compensation



    5,344





    5,412





    15,668





    15,571

    Non-GAAP operating income

    $

    38,874



    $

    55,768



    $

    108,441



    $

    176,247

    Non-GAAP operating margin



    18.2 %





    21.7 %





    18.1 %





    23.0 %

























    GAAP income tax provision

    $

    4,164



    $

    6,789



    $

    12,290



    $

    20,593

    Income tax effect of Non-GAAP

    adjustments2



    1,940





    1,240





    3,542





    2,798

    Non-GAAP income tax provision

    $

    6,104



    $

    8,029



    $

    15,832



    $

    23,391

























    GAAP net income

    $

    25,986



    $

    48,576



    $

    85,941



    $

    151,036

    Transaction and integration3



    8,274





    -





    8,274





    -

    Bad debt expense



    -





    3,443





    -





    2,984

    Restructuring1



    236





    -





    1,356





    1,429

    Stock-based compensation



    5,344





    5,412





    15,668





    15,571

    Income tax effect of Non-GAAP

    adjustments2



    (1,940)





    (1,240)





    (3,542)





    (2,798)

    Non-GAAP net income

    $

    37,900



    $

    56,191



    $

    107,697



    $

    168,222

























    GAAP diluted EPS

    $

    0.83



    $

    1.49



    $

    2.70



    $

    4.61

    Transaction and integration3



    0.26





    -





    0.26





    -

    Bad debt expense



    -





    0.11





    -





    0.09

    Restructuring1



    0.01





    -





    0.04





    0.04

    Stock-based compensation



    0.17





    0.16





    0.49





    0.48

    Income tax effect of Non-GAAP

    adjustments2



    (0.06)





    (0.04)





    (0.11)





    (0.09)

    Non-GAAP diluted EPS

    $

    1.21



    $

    1.72



    $

    3.38



    $

    5.13















































    Note 1: Restructuring and other costs primarily related to early retirement programs and severance costs, due to global cost-saving initiatives.

    Note 2: Impact of taxes from non-GAAP adjustments, uses adjusted tax rate of 14%.

    Note 3: Transaction and integration costs include expenses associated with the merger agreement with Veeco Instruments, announced on October 1,

    2025.

     





     

     

    Axcelis Technologies, Inc

    Reconciliation of Net Income to Adjusted EBITDA

    (In thousands, except percentages)

     









    Three months ended September 30,







    Nine months ended September 30,







    2025





    2024





    2025





    2024

    Net Income

    $

    25,986



    $

    48,576



    $

    85,941



    $

    151,036

    Other (income)/expense



    (5,130)





    (8,452)





    (15,088)





    (15,366)

    Income tax provision



    4,164





    6,789





    12,290





    20,593

    Depreciation & amortization



    4,328





    3,906





    13,152





    11,542

    Subtotal



    29,348





    50,819





    96,295





    167,805

    Transaction and integration2



    8,274





    -





    8,274





    -

    Bad debt expense



    -





    3,443





    -





    2,984

    Restructuring1



    236





    -





    1,356





    1,429

    Stock-based compensation



    5,344





    5,412





    15,668





    15,571

    Adjusted EBITDA

    $

    43,202



    $

    59,674



    $

    121,593



    $

    187,789

    Adjusted EBITDA margin



    20.2 %





    23.3 %





    20.2 %





    24.5 %









































    Note 1: Restructuring and other costs primarily related to early retirement programs and severance costs, due to global cost-saving initiatives.

    Note 2: Transaction and integration costs include expenses associated with the merger agreement with Veeco Instruments, announced on October 1,

    2025.

     













     

    Axcelis Technologies, Inc

    Fourth Quarter Outlook

    GAAP to Non-GAAP Diluted Earnings Per Share

     





    Three months ended

    December 31, 2025



    GAAP diluted EPS

    $

    0.76



    Transaction and Integration2



    0.19



    Restructuring3



    0.05



    Stock-based compensation



    0.18



    Income tax effect of non-GAAP adjustments1

    (0.06)



    Non-GAAP diluted EPS

    $

    1.12

















    Note 1: Impact of taxes from non-GAAP adjustments, uses adjusted tax rate of 14%.

    Note 2: Transaction and Integration costs include expenses associated with the merger agreement with Veeco Instruments, announced on October 1,

    2025.

    Note 3: Restructuring and other costs primarily related to early retirement programs and severance costs, due to global cost-saving initiatives.

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/axcelis-announces-financial-results-for-third-quarter-2025-302603601.html

    SOURCE Axcelis Technologies, Inc.

    Get the next $ACLS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACLS

    DatePrice TargetRatingAnalyst
    10/13/2025$90.00Neutral → Underperform
    BofA Securities
    10/2/2025$105.00Hold → Buy
    The Benchmark Company
    4/21/2025$50.00Buy → Neutral
    B. Riley Securities
    2/12/2025Outperform → Mkt Perform
    William Blair
    11/8/2024Buy → Hold
    The Benchmark Company
    5/3/2024$130.00Hold → Buy
    Craig Hallum
    12/15/2023Buy → Neutral
    BofA Securities
    9/15/2023$225.00Buy
    BofA Securities
    More analyst ratings

    $ACLS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Axcelis Tech downgraded by BofA Securities with a new price target

    BofA Securities downgraded Axcelis Tech from Neutral to Underperform and set a new price target of $90.00

    10/13/25 8:47:48 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    Axcelis Tech upgraded by The Benchmark Company with a new price target

    The Benchmark Company upgraded Axcelis Tech from Hold to Buy and set a new price target of $105.00

    10/2/25 8:33:47 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    Axcelis Tech downgraded by B. Riley Securities with a new price target

    B. Riley Securities downgraded Axcelis Tech from Buy to Neutral and set a new price target of $50.00

    4/21/25 8:31:51 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    $ACLS
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Axcelis Technologies Inc.

    SCHEDULE 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)

    11/14/25 9:46:27 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    SEC Form 10-Q filed by Axcelis Technologies Inc.

    10-Q - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)

    11/6/25 3:37:06 PM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    Axcelis Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)

    11/4/25 8:17:40 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    $ACLS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP AND CFO Coogan James Gordon covered exercise/tax liability with 713 shares, decreasing direct ownership by 2% to 38,944 units (SEC Form 4)

    4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)

    10/17/25 5:05:05 PM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    EVP MARKETING AND APPLICATIONS Redinbo Greg covered exercise/tax liability with 208 shares, decreasing direct ownership by 0.63% to 32,661 units (SEC Form 4)

    4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)

    9/17/25 5:05:05 PM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    EVP Global Customer Operations Tatnall Christopher covered exercise/tax liability with 137 shares, decreasing direct ownership by 0.56% to 24,304 units (SEC Form 4)

    4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)

    9/17/25 5:05:07 PM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    $ACLS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Low Russell bought $49,452 worth of shares (440 units at $112.39), increasing direct ownership by 0.77% to 57,754 units (SEC Form 4)

    4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)

    3/11/24 4:15:28 PM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    Coogan James Gordon bought $11,223 worth of shares (100 units at $112.23), increasing direct ownership by 2% to 5,991 units (SEC Form 4)

    4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)

    2/29/24 4:15:26 PM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    Lawson Douglas A. bought $55,520 worth of shares (500 units at $111.04), increasing direct ownership by 3% to 19,648 units (SEC Form 4)

    4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)

    2/26/24 8:15:07 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    $ACLS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Axcelis Announces Participation in Upcoming Investor Conferences

    BEVERLY, Mass., Nov. 6, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced the company's plans to participate in the following upcoming investor conferences: The Wells Fargo 9th Annual TMT Summit on November 18, 2025 at the Terranea Resort, Rancho Palos Verdes, CA.The 14th Annual NYC Summit on December 16, 2025 at Mastro's Steakhouse, New York, NY.About Axcelis:Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity s

    11/6/25 8:00:00 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    Axcelis Announces Financial Results for Third Quarter 2025

    Q3 Highlights: Revenue of $213.6 millionGAAP Gross Margin of 41.6%, and Non-GAAP Gross Margin of 41.8%GAAP Operating Margin of 11.7% and Non-GAAP Operating Margin of 18.2%GAAP Diluted earnings per share of $0.83, and Non-GAAP Diluted earnings per share of $1.21BEVERLY, Mass., Nov. 4, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the third quarter ended September 30, 2025. President and CEO Russell Low commented, "We delivered another solid quarter, with sales and earnings both exceeding our expectations. We are also pleased

    11/4/25 7:00:00 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    Axcelis Announces Timing and Availability of Third Quarter 2025 Results and Conference Call

    BEVERLY, Mass., Oct. 22, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the third quarter 2025 before the opening of the market on Tuesday, November 4, 2025. The Company will host a call the same day to discuss the results at 8:30 a.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a participant here:https://register-conf.media-server.c

    10/22/25 8:00:00 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    $ACLS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Axcelis Technologies Inc.

    SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)

    11/8/24 2:17:22 PM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    SEC Form SC 13G/A filed by Axcelis Technologies Inc. (Amendment)

    SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)

    2/13/24 4:58:56 PM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    SEC Form SC 13G/A filed by Axcelis Technologies Inc. (Amendment)

    SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)

    2/9/24 4:18:00 PM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    $ACLS
    Financials

    Live finance-specific insights

    View All

    Axcelis Announces Financial Results for Third Quarter 2025

    Q3 Highlights: Revenue of $213.6 millionGAAP Gross Margin of 41.6%, and Non-GAAP Gross Margin of 41.8%GAAP Operating Margin of 11.7% and Non-GAAP Operating Margin of 18.2%GAAP Diluted earnings per share of $0.83, and Non-GAAP Diluted earnings per share of $1.21BEVERLY, Mass., Nov. 4, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the third quarter ended September 30, 2025. President and CEO Russell Low commented, "We delivered another solid quarter, with sales and earnings both exceeding our expectations. We are also pleased

    11/4/25 7:00:00 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    Axcelis Announces Timing and Availability of Third Quarter 2025 Results and Conference Call

    BEVERLY, Mass., Oct. 22, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the third quarter 2025 before the opening of the market on Tuesday, November 4, 2025. The Company will host a call the same day to discuss the results at 8:30 a.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a participant here:https://register-conf.media-server.c

    10/22/25 8:00:00 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    Axcelis Technologies and Veeco Instruments to Combine, Creating a Leading Semiconductor Equipment Company

    Diversifies Portfolio with Complementary Capital Equipment Solutions and Expands Addressable Markets Supported by Secular Tailwinds Greater R&D Scale to Fuel Differentiated, Next-Generation Technologies for Customers Resilient Pro-Forma Operating Profile and Balance Sheet to Support Investment in Organic Growth Initiatives and Share Repurchase Program Expected to be Accretive to Non-GAAP Earnings Per Share Within the First Year Post Closing Will Host Joint Conference Call and Webcast Today at 8:30 AM ET BEVERLY, Mass., and PLAINVIEW, N.Y., Oct. 1, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) and Veeco Instruments Inc. (NASDAQ:VECO) today announced that they have entered in

    10/1/25 7:00:00 AM ET
    $ACLS
    $VECO
    Industrial Machinery/Components
    Technology

    $ACLS
    Leadership Updates

    Live Leadership Updates

    View All

    Axcelis Technologies Appoints David Ryzhik Senior Vice President of Investor Relations and Corporate Strategy

    The Company Announces Planned Retirement of Doug Lawson, Executive Vice President of Corporate Marketing and Strategy BEVERLY, Mass., June 27, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today named David Ryzhik as Senior Vice President of Investor Relations and Corporate Strategy, assuming responsibility for the role in July 2024. The Company also announced the retirement of Doug Lawson, Executive Vice President of Corporate Marketing and Strategy. Mr. Lawson plans to retire in July 2024 and will remain as a Senior Advisor through July 2025.

    6/27/24 4:01:00 PM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    Axcelis Announces Shipment of 'Purion EXE SiC Power Series' Implanter and Successful 'Purion H200 SiC Power Series' Eval Closure at Leading Power Device Manufacturers in Japan

    BEVERLY, Mass., April 2, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today a shipment of the Company's Purion EXE™ SiC high energy implanter as well as a successful Purion H200™ SiC medium energy implanter evaluation closure at leading power device chipmakers located in Japan. The systems will be used for 150mm and 200mm production of silicon carbide power devices supporting automotive, industrial, energy, and other power intensive applications. Greg Redinbo,

    4/2/24 8:00:00 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    ClearPoint Neuro, Inc. Announces Appointment of Lynnette C. Fallon to Board of Directors

    SOLANA BEACH, Calif., July 15, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global therapy-enabling platform company providing navigation and delivery to the brain, is pleased to announce that Lynnette C. Fallon has been appointed to the Company's Board of Directors effective immediately. Ms. Fallon will also become a member of the Company's Audit Committee. Ms. Fallon is the Executive Vice President, HR/Legal, General Counsel and Secretary of Axcelis Technologies, Inc. (NASDAQ:ACLS), a provider of equipment and service solutions for the semiconductor manufacturing industry, with locations in eight countries. Ms. Fallon has held her current position sin

    7/15/21 4:30:00 PM ET
    $CLPT
    $ACLS
    Medical/Dental Instruments
    Health Care
    Industrial Machinery/Components
    Technology